I actually think $1 will be on the cards sooner than you think if results can be clinically accurate, the revenue potential is mind blowing if you do the figures. 40 to 50 percent of all doctor visits are respiratory related and Telehealth is one of the fastest growing businesses in the world. We have a product that no one else has and a patent on it for 10 or so years.
Anyway hope this time we come out the good side of the trading halt and the world headlines tell the story.
Regards
Bloky
- Forums
- ASX - By Stock
- RAP
- Ann: ResApp Provides SMARTCOUGH-C-2 Study Update
Ann: ResApp Provides SMARTCOUGH-C-2 Study Update, page-49
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
-
- There are more pages in this discussion • 21 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)